Aandelen in “Biotechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
C4 Therapeutics Inc |
1/05 | 6,540 USD
+3,81% |
+3,81% |
|
Cabaletta Bio Inc |
1/05 | 12,410 USD
+16,58% |
+16,58% |
|
Calithera Biosciences Inc |
1/05 | 0,020 USD
0,00% |
0,00% |
|
Can-Fite Biopharma Ltd |
1/05 | 2,090 USD
+0,97% |
+0,97% |
|
Capricor Therapeutics Inc |
1/05 | 5,330 USD
+1,14% |
+1,14% |
|
Cara Therapeutics Inc |
1/05 | 0,759 USD
+0,89% |
+0,89% |
Carbios |
30/04 | 22,850 EUR
-0,22% |
-0,22% |
|
Carisma Therapeutics, Inc. |
1/05 | 1,630 USD
0,00% |
0,00% |
|
CASI Pharmaceuticals Inc |
1/05 | 2,390 USD
+1,53% |
+1,53% |
|
Catalyst Biosciences Inc |
30/10 | 0,511 USD
-2,65% |
-2,65% |
Ceapro Inc. |
1/05 | 0,245 CAD
+2,08% |
+2,08% |
|
Cel-Sci Corp. |
1/05 | 1,420 USD
-2,74% |
-2,74% |
|
Celldex Therapeutics Inc. |
1/05 | 39,350 USD
+5,16% |
+5,16% |
|
Cellectar Biosciences Inc |
1/05 | 3,160 USD
+2,27% |
+2,27% |
|
Cellectis |
30/04 | 2,435 EUR
-0,61% |
-0,61% |
|
Cellectis |
1/05 | 2,536 USD
-0,94% |
-0,94% |
|
Celyad Oncology |
20/07 | 0,524 USD
-5,42% |
-5,42% |
Celyad Oncology |
30/04 | 0,325 EUR
-1,52% |
-1,52% |
|
Champions Oncology Inc |
1/05 | 4,860 USD
+0,21% |
+0,21% |
|
Chimerix Inc |
1/05 | 0,950 USD
+1,06% |
+1,06% |
|
Chinook Therapeutics Inc |
10/08 | 40,390 USD
+0,22% |
+0,22% |
|
Cidara Therapeutics Inc |
1/05 | 11,810 USD
-1,42% |
-1,42% |
|
Clovis Oncology Inc |
21/02 | 0,090 USD
+18,42% |
+18,42% |
|
Co-Diagnostics Inc |
1/05 | 1,190 USD
+2,59% |
+2,59% |
|
Cogent Biosciences Inc |
1/05 | 6,930 USD
+6,62% |
+6,62% |
|
CohBar Inc |
29/04 | 0,860 USD
-2,28% |
-2,28% |
|
Coherus Biosciences Inc |
1/05 | 2,060 USD
+5,10% |
+5,10% |
|
CollPlant Biotechnologies Ltd |
1/05 | 5,780 USD
-1,70% |
-1,70% |
|
Compass Pathways Plc |
1/05 | 8,480 USD
-1,05% |
-1,05% |
|
Compugen Ltd. |
1/05 | 1,990 USD
+3,11% |
+3,11% |
|
Concert Pharmaceuticals Inc |
4/04 | 8,370 USD
0,00% |
0,00% |
|
ContraFect Corp |
6/02 | 0,033 USD
+8,73% |
+8,73% |
|
Corbus Pharmaceuticals Holdings Inc |
1/05 | 37,250 USD
+0,57% |
+0,57% |
|
CRISPR Therapeutics AG |
1/05 | 53,810 USD
+1,55% |
+1,55% |
|
Cue Biopharma Inc |
1/05 | 1,905 USD
+0,26% |
+0,26% |
|
Curis Inc |
1/05 | 15,990 USD
+4,17% |
+4,17% |
|
Cyclacel Pharmaceuticals Inc |
1/05 | 7,350 USD
-12,91% |
-12,91% |
|
Cyclacel Pharmaceuticals Inc |
1/05 | 2,650 USD
+25,00% |
+25,00% |
|
Cymabay Therapeutics Inc |
21/03 | 32,480 USD
+0,03% |
+0,03% |
|
Cytokinetics Inc |
1/05 | 63,370 USD
+3,34% |
+3,34% |
|
CytomX Therapeutics Inc |
1/05 | 5,130 USD
+214,72% |
+214,72% |
Cytotools AG |
30/04 | 0,486 EUR
-0,41% |
-0,41% |